CAR T-Cell Therapy Remain Effective in Patients with Relapse/Refractory B-Cell Non-Hodgkin Lymphoma after Bispecific Antibodies Exposure: Results of a Lysa Study Based on the Descar-T Registry

Autor: Crochet, Gilles *, Audrey, Couturier *, Bachy, Emmanuel *, Gastinne, Thomas *, Cartron, Guillaume *, Fradon, Tom *, Gounot, Romain *, Castilla-LLorente, Cristina *, Sarkozy, Clementine *, Camus, Vincent *, Guidez, Stéphanie *, Chauchet, Adrien *, Deconinck, Eric *, Bouabdallah, Krimo *, Morschhauser, Franck *, Houot, Roch *
Zdroj: In Blood 15 November 2022 140 Supplement 1:4639-4641
Databáze: ScienceDirect